Exploring the Prognostic Role of Neurofilaments and SEMA3A in Multiple Sclerosis Progression
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26178750 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Zbyšek Pavelek und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Faculty of Medicine in Hradec Králové, Charles University, 50005 Hradec Králové, Czech Republic. Hauptthemen laut MEDLINE: Semaphorin-3A, Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Relapsing-Remitting, Intermediate Filaments. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Charles University, Czech Republic (Cooperatio Program, research area NEUR),, the Ministry of Health of the Czech Republic, Charles University, Czech Republic (Cooperatio Program, research area NEUR).
Abstract (Originalsprache)
The transition from relapsing–remitting multiple sclerosis (RRMS) to secondary progressive multiple sclerosis (SPMS) is characterized by an increasing neurodegenerative component. Identifying biomarkers that distinguish these disease stages is crucial for early diagnosis and treatment optimization. This study aimed to compare serum levels of progranulin, interleukin-6 (IL-6), semaphorin 3A (SEMA3A), and neurofilaments between RRMS and SPMS patients and to investigate their correlation with clinical characteristics, including disability measured by the Expanded Disability Status Scale (EDSS). This observational study included 118 MS patients (63 RRMS and 55 SPMS). Serum biomarker levels were measured using an enzyme-linked immunosorbent assay (ELISA). Statistical analyses included group comparisons using non-parametric tests and correlation analyses using Pearson’s correlation coefficient with multiple testing corrections. While demographic and clinical parameters significantly differed between groups (p < 0.001), biomarker levels showed no statistically significant differences (p > 0.05). However, in SPMS patients, SEMA3A correlated positively with neurofilaments (r = 0.359, p = 0.007), and progranulin correlated with IL-6 (r = 0.354, p = 0.008). No significant biomarker correlations with EDSS were found. Although absolute biomarker levels did not distinguish RRMS from SPMS, specific biomarker correlations may reflect processes relevant to disease progression and warrant further longitudinal validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Faculty of Medicine in Hradec Králové, Charles University, 50005 Hradec Králové, Czech Republic.
- Department of Neurology, University Hospital Hradec Králové, 50005 Hradec Králové, Czech Republic.
- Department of Clinical Immunology and Allergology, University Hospital Hradec Králové, 50005 Hradec Králové, Czech Republic.
- Novartis, s.r.o., 14000 Prague, Czech Republic.
ORCID-Profile: Zbyšek Pavelek, Ondřej Souček, Lukáš Sobíšek
Förderung
- Charles University, Czech Republic (Cooperatio Program, research area NEUR),
- the Ministry of Health of the Czech Republic
- Charles University, Czech Republic (Cooperatio Program, research area NEUR)
- Ministry of Health of the Czech Republic
Zitieren
APA
Pavelek, Z., Souček, O., Krejsek, J., Součková, I., Popovičová, A., Matyáš, D., Sobíšek, L., & Novotný, M. (2025). Exploring the Prognostic Role of Neurofilaments and SEMA3A in Multiple Sclerosis Progression. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26178750
Vancouver
Pavelek Z, Souček O, Krejsek J, Součková I, Popovičová A, Matyáš D, et al. Exploring the Prognostic Role of Neurofilaments and SEMA3A in Multiple Sclerosis Progression. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26178750
BibTeX
@article{Pavelek2025,
author = {Pavelek, Zbyšek and Souček, Ondřej and Krejsek, Jan and Součková, Ilona and Popovičová, Andrea and Matyáš, David and Sobíšek, Lukáš and Novotný, Michal},
title = {Exploring the Prognostic Role of Neurofilaments and SEMA3A in Multiple Sclerosis Progression},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26178750}
}
EUVIMED